18-Dec-2013 - Encap has collaborated with Lipocine to manufacture its oral testosterone product and says it expects continued growth in demand for HPAPI formulation services.
25-Nov-2013 - Pfizer says it intends to shutter a manufacturing facility in Puerto Rico just days after Merck & Co. announced it was reducing its footprint on the island.
21-Nov-2013 - Aptar Pharma has launched a new auto-injector technology as part of a strategic effort to build its presence in the biopharmaceutical sector.
04-Nov-2013 - Granules India has outlined plans to buy drug intermediate and API maker Auctus Pharma, set up an actives R&D site and announced its intention to wind up its ‘shell’ operation...
31-Oct-2013 - The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the firms say, as the first drug delivery tech is transferred.
23-Oct-2013 - Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.
15-Oct-2013 - AstraZeneca has become the latest company to invest in antibody-drug conjugate (ADC) technology with the acquisition of Spirogen for $200m (€148m).
09-Oct-2013 - Merck says it is shutting two New Jersey facilities as it moves its headquarters to the Kenilworth site where manufacturing ended last week.
05-Sep-2013 - Capsugel will buy Bend Research to expand its dosage form solutions (DFS) business in a deal announced earlier today.
05-Sep-2013 - GlaxoSmithKline is in talks with a number of companies interested in buying its Romanian manufacturing facility that was recently earmarked for closure.
02-Sep-2013 - Novartis-owned Chiron and Panacea Biotec have amicably dissolved their vaccine joint venture due to strategic regions, according to Novartis.
29-Aug-2013 - ICIG will buy the Belgian operation of peptide maker Peptisyntha SA from Solvay to expand its recently rejigged contract API business.
28-Aug-2013 - Amgen spent $10.4bn (€7.8bn) this week on Onyx Pharmaceuticals, but AstraZeneca and Johnson & Johnson have also opened up their wallets this week – welcome to in-Pharmatechnologist.com’s merger & acquisition...
26-Aug-2013 - Amgen has spent $10.4bn (€7.8bn) in acquiring Onyx Pharmaceuticals saying its oncology products and pipeline will be strengthened by Amgen’s manufacturing capabilities.
20-Aug-2013 - Fresenius Kabi will focus on intravenous generics and infusion solutions as it acquires a 51 percent stake in an Indonesian pharma company.
14-Aug-2013 - Pharmstandard says the acquisition of Bever Pharmaceuticals will lower the cost of its API supply as it plans to spin out an OTC business.
13-Aug-2013 - Consolidating its Indian injectable business under a new subsidiary will improve focus and align quality control, says Aurobindo who has invested in two manufacturing companies to support such plans.
06-Aug-2013 - Enteris has acquired an oral drug delivery platform from Unigene Laboratories and says the excipients used can increase solubility and absorption for both peptides and small molecules.
06-Aug-2013 - Merck & Co. will close the doors on its Kenilworth, New Jersey manufacturing plant affecting 100 jobs in a continuation of its consolidation efforts.
05-Aug-2013 - Kemwell has positioned a foothold in the US with the acquisition of drug delivery research firm Cirrus Pharmaceuticals.
31-Jul-2013 - Medicines New Zealand has merged with the Vaccines Industry Association of New Zealand (VIANZ) in order to share resources and provide a single point of contact for all stakeholders.
30-Jul-2013 - Valeant says it will slash its workforce by up to 15% and consolidate some of its non-US locations following the acquisition of Bausch & Lomb.
25-Jul-2013 - Tasi Group has acquired pharmaceutical leak testing firm Sepha and plans to seek more customers overseas.
09-Jul-2013 - Teva says it will reap the benefits of changing attitudes to generic drugs in Japan as it doubles its production capacity in the country.
18-Jun-2013 - Teva has affirmed its respiratory drug delivery strategy with the purchase of MicroDose Therapeutx for a potential $165m (€123m).